VesselAlert
Name: LILLY
MMSI: 211750930
Callsign: DF8503
Flag: Germany
Seen: 15-Oct-2026 22:24:16 CEST
Speed: 0.1 kts
Dest.: LEER ORT
Distance: 53.2 nm
Signal RSSI: 0.0 dBFS
Ship AIS VesselAlert © kx1t - link

Eli Lilly's Omvoh Gains Ground in Ulcerative Colitis and Crohn's: New Data Poised to Challenge
#LLY #Lilly #Markets https://financier.news/eli-lillys-omvoh-gains-ground-in-ulcerative-colitis-and-crohns-new-data-poised-to-challenge-abbvies-skyrizi-and-jjs-stelara-in-a-20-billion-ibd-market-lly/
咲きたてで黄色い花粉がビッシリです。
#タカサゴユリ
#photography #natures #flower #Lilly
真夏の花の #タカサゴユリ が残っていました。
色んな葉っぱをかき分けて頭を出しています。
やっぱり10月に咲くのは大変なようで
花びらが荒れてますね
#photography #natures #flower #Lilly
💊 RBC Backs Eli Lilly as Incretin Momentum Lifts Stock to 86th Percentile
RBC Capital reiterated its rating on Eli Lilly, citing momentum in its incretin franchise. LLY trades at 1,179.27, up 0.83% today.
💊 RBC Backs Eli Lilly as Incretin Momentum Lifts Stock to 86th Percentile
RBC Capital reiterated its rating on Eli Lilly, citing momentum in its incretin franchise. LLY trades at 1,179.27, up 0.83% today.
🩺 Lilly-Backed TRex Bio Closes Flat at $14 After $117M IPO
Eli Lilly-backed TRex Bio closed its first trading day flat at its $14 IPO price, raising $117M. Shares opened at $13.50, dipped below $14, spiked to $15.50 late, then settled.
💊 Eli Lilly GLP-1 Franchise Hits $15.7B Revenue, Growing 76% as Stock Slips
Mounjaro and Zepbound now generate $15.7B in combined revenue, up 76%, keeping Eli Lilly's weight-loss franchise the sector's dominant money machine.
New Insights from Eli Lilly's Clinical Trials on Psoriasis Treatment Revealed #USA #Indianapolis #Zepbound #Lilly #Taltz
💊 Eli Lilly Jumps 2.20% to $1,182.91 as GLP-1 Franchise Drives Premium Valuation
Eli Lilly shares climbed 2.20% to $1,182.91, sitting in the 87th percentile of their 52-week range as investors keep paying up for the company's obesity and diabetes portfolio.
🧠Meet Dr Kálmán Benedikt Bódis, #EFSD & #Lilly Young Investigator Research Award recipient. His project explores how restoring blood flow affects wound microbiome in #diabeticfoot ulcers for more personalised treatment.
📖 link.springer.com/article/10.1...
Supported by Lilly Diabetes International.
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
replaye.com/why-lilly-an...
#News #Lilly #Novo #EliLilly #Amylin #ObesityDrugs #Drugs #GLP1 #Health
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump's plan to lower Medicare drug prices, a Lilly obesity drug, and more news.. statnews.com/pharmalot/20... #pharma #Trump #Medicare #obesity #weight #layoffs #FDA #animals #Lilly #Novo #AstraZeneca #Sanofi #Regeneron
🥇 Lilly Slides 2% As EASD Deck Lands With No New Guidance
Eli Lilly presented at the 2026 EASD annual meeting, publishing a slide deck tied to the event.
Shares fell 2.02% to 1,160.75, holding the 82nd percentile of the 52-week range after a 7.44% YTD run.
Besutiful #Lilly needs a loving furrever family today! 💔
Please at least SHARE!! 🙏🐾